December 9-12, 2023

65th American Society of Hematology (ASH) annual meeting

Stephen Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer presented “In Vivo Generation of Functional CD19 CAR-T Cells Using a Serum-Stable CD3-Targeting Lentiviral Vector” at the 65^th Annual ASH meeting in San Diego, CA. Kah-Whye Peng, Ph.D., Vyriad Co-Founder and Chief Technical Officer; Luke Russell, Ph.D., Vyriad Director for Business Development & Strategic Alliances and Morgan Le Naour, Vyriad Business Development and Alliance Associate attended the 65^th ASH meeting in San Diego, CA